Pacific Biosciences of California, Inc.

DB:P09 Stock Report

Market Cap: €480.3m

Pacific Biosciences of California Management

Management criteria checks 2/4

Pacific Biosciences of California's CEO is Christian O. Henry, appointed in Sep 2020, has a tenure of 4.33 years. total yearly compensation is $8.05M, comprised of 8.6% salary and 91.4% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth €681.35K. The average tenure of the management team and the board of directors is 4.2 years and 11.9 years respectively.

Key information

Christian O. Henry

Chief executive officer

US$8.0m

Total compensation

CEO salary percentage8.6%
CEO tenure4.3yrs
CEO ownership0.1%
Management average tenure4.2yrs
Board average tenure11.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Christian O. Henry's remuneration changed compared to Pacific Biosciences of California's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$394m

Jun 30 2024n/an/a

-US$400m

Mar 31 2024n/an/a

-US$297m

Dec 31 2023US$8mUS$695k

-US$307m

Sep 30 2023n/an/a

-US$309m

Jun 30 2023n/an/a

-US$319m

Mar 31 2023n/an/a

-US$321m

Dec 31 2022US$7mUS$667k

-US$314m

Sep 30 2022n/an/a

-US$299m

Jun 30 2022n/an/a

-US$206m

Mar 31 2022n/an/a

-US$175m

Dec 31 2021US$3mUS$650k

-US$181m

Sep 30 2021n/an/a

-US$37m

Jun 30 2021n/an/a

-US$77m

Mar 31 2021n/an/a

-US$59m

Dec 31 2020US$13mUS$195k

US$29m

Sep 30 2020n/an/a

-US$46m

Jun 30 2020n/an/a

-US$51m

Mar 31 2020n/an/a

-US$53m

Dec 31 2019US$100kn/a

-US$84m

Sep 30 2019n/an/a

-US$115m

Jun 30 2019n/an/a

-US$111m

Mar 31 2019n/an/a

-US$109m

Dec 31 2018US$88kn/a

-US$103m

Compensation vs Market: Christian O.'s total compensation ($USD8.05M) is above average for companies of similar size in the German market ($USD984.62K).

Compensation vs Earnings: Christian O.'s compensation has increased whilst the company is unprofitable.

CEO

Christian O. Henry (56 yo)

4.3yrs

Tenure

US$8,046,575

Compensation

Mr. Christian O. Henry, MBA, served as Independent Director at CM Life Sciences III Inc. since April 07, 2021 until December 2021. He has been President and Chief Executive Officer at Pacific Biosciences o...

Leadership Team

NamePositionTenureCompensationOwnership
Christian O. Henry
President4.3yrsUS$8.05m0.14%
€ 681.4k
Mark Van Oene
Chief Operating Officer4yrsUS$4.60m0.12%
€ 554.9k
Stephen Turner
Co-Founder24.5yrsUS$466.76kno data
Michele Farmer
VP & Chief Accounting Officer3.7yrsno data0.013%
€ 63.5k
Brett Atkins
General Counsel & Corporate Secretaryno datano datano data
Natalie Welch
Chief People Officerno datano datano data

4.2yrs

Average Tenure

53.5yo

Average Age

Experienced Management: P09's management team is considered experienced (4.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Christian O. Henry
President6.5yrsUS$8.05m0.14%
€ 681.4k
William Ericson
Independent Director21yrsUS$259.00k0.0069%
€ 33.0k
Lucy Shapiro
Independent Director12.3yrsUS$255.00k0%
€ 0
John Milligan
Independent Chairman11.5yrsUS$297.00k0.040%
€ 193.0k
Harry Gray
Member of the Scientific Advisory Boardno datano datano data
Joseph Bonventre
Member of the Scientific Advisory Boardno datano datano data
Randall Livingston
Independent Director16yrsUS$265.00k0%
€ 0
Harold Craighead
Member of the Scientific Advisory Boardno datano datano data
Roger Kornberg
Member of the Scientific Advisory Boardno datano datano data
Watt Webb
Member of the Scientific Advisory Boardno datano datano data
Kenneth Johnson
Member of the Scientific Advisory Boardno datano datano data
Jay Shendure
Chairman of Scientific Advisory Board2.2yrsno datano data

11.9yrs

Average Tenure

70yo

Average Age

Experienced Board: P09's board of directors are seasoned and experienced ( 11.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 08:59
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pacific Biosciences of California, Inc. is covered by 24 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Luke SergottBarclays
Kyle MiksonCanaccord Genuity
Bryan BrokmeierCantor Fitzgerald & Co.